Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Other Operating Expenses of -$18.1 million for Q1 2026, down 7.0% quarter-over-quarter from -$16.9 million in Q4 2025.
Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026) Analysis & Trends
Scilex Holding's Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$18.1 million for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to -$18.1 million; the TTM figure through Mar 2026 stood at -$25.9 million (down 579.86% YoY), while the FY2025 annual figure was -$12.2 million, changed N/A from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$18.1 million, down from -$16.9 million in the prior quarter.
- The five-year high for Other Operating Expenses was $5.5 million in Q4 2023, with the low at -$18.1 million in Q1 2026.
- The 5-year median for Other Operating Expenses is $4.4 million (2023), against an average of $448266.0.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses soared 6706.96% in 2023, then slumped 143.83% in 2024.
- Scilex Holding's Other Operating Expenses stood at $5.5 million in 2022, then climbed by 0.14% to $5.5 million in 2023, then fell by 2.81% to $5.4 million in 2024, then sank by 413.15% to -$16.9 million in 2025, then decreased by 7.0% to -$18.1 million in 2026.
- Business Quant data shows SCLX's Other Operating Expenses at -$18.1 million in Q1 2026, -$16.9 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.06 Mn |
| Dec 31, 2025 | -16.88 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Mar 31, 2024 | -2.02 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.62 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 526,359.00 |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | -69,896.00 |
| Dec 31, 2021 | -259,559.00 |
| Sep 30, 2021 | -1.16 Mn |
| Jun 30, 2021 | -61,609.00 |
| Mar 31, 2021 | 1.49 Mn |
| Dec 31, 2020 | 6,276.00 |
| Sep 30, 2020 | 5,856.00 |